Study Comparing Radioembolization and External Radiation Therapy for Liver Cancer
Sponsor: Henry Ford Health System
ClinicalTrials ID:NCT07530172
This clinical trial is comparing two different radiation treatments, radioembolization and external radiation therapy, to see which is more effective and better tolerated for treating liver cancer.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The study aims to compare the effectiveness and safety of two radiation treatments for liver cancer: transarterial radioembolization (TARE) and stereotactic body radiation therapy (SBRT). In the SBRT group, patients will receive standard radiation therapy over 3 to 5 sessions, with doses adjusted for safety. In the TARE group, patients will undergo a procedure to deliver a radioactive substance, Yttrium-90, directly to the liver tumor through the blood vessels. The main goal is to see how often the treated tumor needs additional treatment within 12 months.
Eligibility Criteria
Inclusion Criteria
- Able to provide written consent and agree to follow study procedures.
- Available for the entire duration of the study.
- Male or female, 18 years or older.
- Have no more than 3 liver cancer lesions suitable for TARE or SBRT.
- Child-Pugh score of 8 or less, indicating liver function.
- ECOG performance status of 2 or less, indicating general health.
- Adequate organ function, with specific blood test results:
- Bilirubin level less than 4.0 mg/dL.
- Albumin level greater than 2 g/dL.
Exclusion Criteria
- Previous SBRT or radioembolization treatment to the target tumor.
- Large blood vessel invasion by the tumor.
- Planned or recommended additional systemic therapy.
- Pregnant or breastfeeding women. Women who can become pregnant must have a negative pregnancy test within 14 days before joining the study.
- Severe allergic reaction to iodinated contrast used in imaging tests.
- Blood clotting issues that make transarterial therapy unsafe.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| Henry Ford Health System | 48202 | Detroit | Michigan |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.
